A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Clinical trial NCT05841030 · COMPLETED

Trial details

NCT number: NCT05841030
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Depressive Disorder, Major

Start date: 2023-04-28
Primary completion: 2026-02-27
Enrollment: 545

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.